Avalo Therapeutics
Founded 2011 · CIK 0001534120 · Biotech · Public
Anti-IL-1beta monoclonal antibody therapeutic
avalotx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $182M
- 6 Form D · Apr 2024
- 30 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 28
- 2 granted · 26 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $22,137,301 | |
| Private capital raised | Form D · SEC | $6,805,883 | |
| Private capital raised | Form D · SEC | $16,259,016 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $130,601,986 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2385 | HiberCell | — | — |
| 2386 | RaeSedo, LLC | — | — |
| 2387 | Rakuten Medical, Inc. | — | $887M |
| 2388 | Avalo Therapeutics | — | $182M |
| 2389 | MOCKV SOLUTIONS INC. | — | — |
| 2390 | SERPIN PHARMA, LLC | — | — |
| 2391 | ZENO MANAGEMENT, INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Thomas AasenDirector
- THOMAS AASENDirector
- June Almenoff, M.D., Ph.D.Director
- Sol BarerDirector
- Eugene BauerDirector
- EUGENE BAUERDirector
- Isaac BlechDirector
- ISAAC BLECHDirector
- John CatsimatidisDirector
- Mitchell ChanDirector
- Bernadine FraserExecutive Officer
- Jonathan Goldman, M.D.Director
- Phil GutryDirector
- PHIL GUTRYDirector
- Uli HacksellDirector · Executive Officer
- ULI HACKSELLDirector · Executive Officer
- John KaiserExecutive Officer
- JOHN KAISERExecutive Officer
- Aaron KantoffDirector
- Gilla Kaplan, Ph.D.Director
- Karen KrumeichExecutive Officer
- Ronald MarcusExecutive Officer
- RONALD MARCUSExecutive Officer
- Reza MazhariExecutive Officer
- Mariam MorrisExecutive Officer
- MARIAM MORRISExecutive Officer
- Garry Neil, M.D.Director · Executive Officer
- Federica O'BrienExecutive Officer
- Blake PatersonDirector · Executive Officer
- Magnus PerssonDirector
- MAGNUS PERSSONDirector
- Magnus Persson, M.D., Ph.D.Director
- Sharon RowlandExecutive Officer
- Behshad SheldonDirector
- Cary SucoffDirector
- Cary Sucoff, Jr.Director
- Mayukh SukhatmeDirector
- Christopher SullivanExecutive Officer
- Frank TortiDirector
- Samantha TruexDirector
- James VornovExecutive Officer
Patents
- Liquid Pharmaceutical Formulations for an Anti-IL-1beta Antibodyapplication
- Methods and Treatment Involving Excess Free LIGHTapplication
- Methods of Treating Hidradenitis Suppurativa with Anti-IL-1beta Antibodiesapplication
- Methods Of Treating Pneumonia Or Respiratory Failure Associated With COVID-19 By Administering An Anti-light Antibodygranted
- Methods of Treating Asthma with Anti-LIGHT Antibodiesapplication
- Methods of Treating Ulcerative Colitis with Anti-LIGHT Antibodiesapplication
- Methods and Treatment for Complex Lymphatic Malformationsapplication
- Methods and Treatment for Adult-Onset Still's Disease and Systemic-Onset Juvenile Idiopathic Arthritis Involving Antibodies to IL-18application
- A Method of Treating Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) Associated with COVID-19 by Administering an anti-LIGHT Antibodygranted
- Method Of Treating Conditions Associated With Elevated INTERLEUKIN-18 (IL-18) By Administering An ANTI-IL-18 Antibodyapplication
- Methods For Treating Symptomatic Orthostatic Hypotensionapplication
- Methods of Treating Asthma with Anti-Light Antibodiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.